Mon.Feb 12, 2024

article thumbnail

Ebola vaccine cuts fatality even in people who were infected before the jab, new study shows

STAT

A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. It confirms just how major an advancement the Ebola vaccine remains; the study is the first to show that in addition to preventing infections, the vaccine can save some people who are already sick with the often fatal disease.

Vaccines 364
article thumbnail

FDA inches closer to defining its regulatory role in AI

PharmaVoice

Commissioner Dr. Robert Califf signals how the FDA will consider AI in drug development and how the agency may use the emerging technology in the future.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Was Pfizer’s “Here’s to Science” commercial during the Super Bowl a winning play or a fumble?

STAT

Super Bowl ads are a show within the show, an opportunity for brands and advertising creatives to put their work in front of more than 100 million viewers. And while the occasion is most closely associated with ads for beer, cars, and soft drinks, pharma giant Pfizer dished out millions of dollars for its own message: “Here’s to science.

Hospitals 355
article thumbnail

A new (old) mind-opening tool in the fight against Alzheimer’s disease

PharmaVoice

A new use for an existing ultrasound technology is seeing early success in getting medications past the blood-brain barrier.

148
148
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease

STAT

A growing body of data show that South Asians are at greater risk of developing heart disease than white people, and they tend to get complications at younger ages, but it’s not been fully clear what explains this disparity. A new study suggests one potential reason is that South Asians have a decreased ability to repair blood vessels that get injured from cardiovascular problems.

363
363
article thumbnail

MHRA agrees licence change for Pfizer-BioNTech’s Comirnaty vaccine

Pharmaceutical Technology

The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.

Vaccines 142

More Trending

article thumbnail

Dermatology pharma Alys launches with $100m from Medicxi

pharmaphorum

Medicxi has combined six biotechs with dermatology medicines in development in a single drugmaker, called Alys Pharma, which starts life with $100 million in financing.

125
125
article thumbnail

No one’s pleased with the government’s pitch for 2025 Medicare Advantage rates

STAT

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  The FTC doubles down on private equity and Big Physician Dominant physician groups don’t command the same attention as, say, Big Tech firms with national omnipresence like Google and Facebook.

Hospitals 335
article thumbnail

Women’s health is a priority not a charity

pharmaphorum

Investing in women's health research and funding is not a charity, but a priority. Discover the importance of allocating resources and supporting initiatives that promote women's health and well-being.

121
121
article thumbnail

STAT+: FTC doubles down in Welsh Carson anesthesia case to limit private equity’s physician buyouts

STAT

Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Last September, the FTC sued private equity firm Welsh, Carson, Anderson & Stowe and U.S. Anesthesia Partners, alleging the two parties conspired to create monopolies for anesthesia services. Both Welsh Carson and USAP have tried to get the case thrown out , but the FTC recently doubled down.

335
335
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Pharmacy First AMR impact under spotlight in £2.4m research project

The Pharmacist

The London School of Hygiene and Tropical Medicine (LSHTM) has been awarded a £2.4m contract by the National Institute for Health and Care Research (NIHR) to monitor the Pharmacy First service in England. The LSHTM research team will work in partnership with experts at the UK Health Security Agency and the Oxford, Manchester and Nottingham […] The post Pharmacy First AMR impact under spotlight in £2.4m research project appeared first on The Pharmacist.

108
108
article thumbnail

STAT+: States are ramping up scrutiny of health transactions, as more provider groups look for buyers

STAT

UnitedHealth Group’s Optum has bought an untold number of physician practices over the years. It either owns or is affiliated with over 90,000 providers — almost 10% of all U.S. physicians. That’s mostly happened quietly. But a new Optum purchase in Oregon is getting outsized scrutiny from state regulators — a trend experts say is actually on the rise.

Hospitals 346
article thumbnail

Apple devices enrich patent data in arthritis trial

pharmaphorum

Study finds that monitoring of rheumatoid arthritis patients with an Apple Watch and iPhone and AI algorithm improves on standard practices.

119
119
article thumbnail

STAT+: Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease

STAT

Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for approval later this year. The deal values CymaBay at $32.50 per share, 27% higher than the stock’s close last Friday. That’s a relatively small takeout premium, but CymaBay shares have doubled in value since last fall on growing investor confidence in the company’s lead drug and speculation that the company could be acquired.

325
325
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

First UK patients receive experimental mRNA therapy for cancer in global trial

Pharma Times

The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359

141
141
article thumbnail

Opinion: How much personal health information does King Charles owe the public?

STAT

On Feb. 5, Buckingham Palace shared the news that King Charles had started treatment for cancer. Although the official statement did not include the particular type of cancer, it closed by noting that, “His Majesty has chosen to share his diagnosis to prevent speculation and in the hope it may assist public understanding for all those around the world who are affected by cancer.

297
297
article thumbnail

Biologics – manufacturing trends in a modern facility

European Pharmaceutical Review

Bringing a therapeutic to market is a long and complex process. ‘From bench to bedside’ is a well-known aphorism that merely hints at the arduous journey drug treatments must undergo from their position as a candidate molecule or soon to be explored pathway, to becoming a tablet, injection, or infusion administered to patients worldwide. The scientific rigour of development and the various regulatory hurdles involved mark most of that journey.

article thumbnail

Psychedelic investment continues to ramp up

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Hope your team of choice was victorious in last night’s sports ball match. Today, we talk about psychedelics, obesity, and production issues with generic drugs. We also discuss the ongoing issues of scientific misconduct that are springing up left and right in academia, and how universities are scrambling to keep up.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Raman and machine learning show promise for online monitoring of bioreactors

European Pharmaceutical Review

Researchers based in France have demonstrated a robust online Raman monitoring model for bioreactors, which combines Raman spectroscopy and machine learning (ML). In the study, the fermentation of alcohol by Saccharomyces cerevisiae ( S. cerevisiae) was used as a benchmark bioprocess. The method was validated across numerous batches and a fed-batch bioreactor.

article thumbnail

Opinion: Dental care is in crisis. But it’s also a moment of opportunity

STAT

While staffing crises at hospitals continue to make headlines, dental care — too often overlooked and treated as separate from medical — is also experiencing a significant workforce challenge. In my role leading dental at Sun Life U.S., which includes DentaQuest, the nation’s largest Medicaid dental benefits organization, I know full well that you cannot be healthy without a healthy mouth.

Diabetes 267
article thumbnail

Gilead to buy liver disease specialist CymaBay for $4.3bn

pharmaphorum

Gilead Sciences has beefed up its pipeline with an agreement to buy CymaBay Therapeutics and its seladelpar drug for primary biliary cholangitis (PBC) for $4.

109
109
article thumbnail

STAT+: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin at a brisk pace. So time to give it a nudge in a better direction with a cup or three of stimulation.

Diabetes 258
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Aparna Group forays into pharma gets USFDA clearance for pharma manufacturing unit

Express Pharma

Aparna Pharmaceuticals announced that its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug Administration (USFDA). The USFDA audited the facility during the month of September 2023. Rakesh Reddy, MD, Aparna Pharmaceuticals said, “This clearance is a testament to our team’s relentless pursuit of excellence.

105
105
article thumbnail

Scientists develop micofluidic chip to make cell therapy safer

Pharma Times

The chip removes cells, which could become tumours, before they are implanted in a patient

127
127
article thumbnail

FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen

pharmaphorum

GSK’s antisense-based drug for chronic hepatitis B, bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval

113
113
article thumbnail

Phesi’s AI-driven Trial Accelerator platform contains over 100 million patients

Pharma Times

The platform delivers digitalised patient data to improve clinical trials and development

127
127
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

NHSE pilot to test new models of vaccination delivery

The Pharmacist

NHS England (NHSE) is launching 12 ‘demonstrator sites’ to test ‘new and innovative’ models of vaccination delivery, it has said. Slides from a webinar aimed at general practitioners last week revealed that the sites would be launched in March, and would explore ‘how more flexible approaches to ICB [Integrated Care Board] commissioning can enable ways […] The post NHSE pilot to test new models of vaccination delivery appeared first on The Pharmacist.

article thumbnail

CSL’s post-heart attack therapy flunks big phase 3 test

pharmaphorum

Biotech giant CSL has seen almost 5% wiped off the value of its shares after one of its most anticipated pipeline products failed a phase 3 trial in heart attack patients

103
103
article thumbnail

NIHR awards over £20m to eight new global health research projects

Pharma Times

The projects will focus on healthcare in LMICs in the event of extreme weather

128
128
article thumbnail

Changing Faces: Agency, consultancy, and investor hires from January 2024

pharmaphorum

Changing Faces: Agency, consultancy, and investor hires from January 2024 highlights the recent hires and movements in prominent companies such as Permira, Cuttsy+Cuttsy, SV Health Investors, and Cure Ventures. Stay updated with the latest talent appointments in the industry.

100
100
article thumbnail

Verisense Health adopts Datavant’s data connectivity platform expanding real-world data sources

Outsourcing Pharma

Verisense Health, Inc., is now able to generate richer patient insights after adopting Datavantâs data connectivity platform.

104
104